In ADPKD mouse models, c-MYC upregulates miR-17 in cystic kidneys, and miR-17 inhibits FAO by directly inhibiting PPARα to reprogram the mitochondrial metabolism. This evidence concerns the gene PPARA and autosomal dominant polycystic kidney disease.